NFE2L2 and breast cancer: In turn, expression of NRF2-dependent genes like HO-1, NQO1, AKR1B10, MRP1, and MRP5 is decreased, as exemplified in breast cancer MCF-7 cells, which have become more susceptible to doxorubicin after chrysin treatment [4,9,30].